Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Transcell Technologies Inc
Profile last edited on: 10/6/2004      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1991
First Award
1995
Latest Award
1995
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

8 Cederbrook Drive
Cranbury, NJ 08512
   (609) 655-6900
   sofia@transcell.com
   www.transcell.com
Location: Single
Congr. District: 12
County: Middlesx

Public Profile

Research and development organization specializing in new pharmaceuticals based on carbohydrates. On March 3, 1998 Transcell Technologies Inc was acquired by Intercardia, Inc. (NASDAQ: ITRC)

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$96,982
Phase II Dollars
$0
Total Awarded
$96,982

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
1995 1 NIH $96,982
Project Title: Novel Antisense DNA Conjugates as Anti-HIV Agents

Key People / Management

  Glenn Cooper -- Acting President

  Michael Sofia

Company News

There are no news available.